Sepragen.com

Home | Contact Us 


Online Catalog


View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at sales@sepragen.com.



How Can We Help You?
Click here to contact us!

 



Sepragen announces the world’s first automated system for packing radial flow columns

February 2010, Hayward, CA ... Sepragen announced the launch of QS Column Packing System, the world’s first automated packing system for packing its innovative Superflo, Radial Flow Columns. The packing skid enables the easy, automated and reproducible packing of production scale Radial Flow columns, minimizing reliance on “technique”. Column packing integrity analysis using HETP and Asymmetry can be determined. Column performance can also be calculated after storage and before re-use. The QS Column packing system consists of a diaphragm pump, various pneumatically actuated diaphragm valves and UV and conductivity sensors. The system is PC controlled. Different protocols can be stored and retrieved for different columns and different resins using the QS packing systems 21 CFR Part11 compliant software. “This is another offering designed to support the users of Sepragen’s Superflo Radial Flow Columns” and take the mystery out of column packing”, Renu Chabra, Sepragen’s Vice president of Engineering commented. “We are all about empowering our customers with greater productivity in bio-processing”.

Sepragen currently provides innovative bio-processing products that enable biotech companies to develop and produce biopharmaceuticals quickly and cost-effectively. Sepragen products are used world-wide by leading biotech companies to manufacture over twenty FDA approved drugs

Return to News and Events main page



The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.


Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2017 Sepragen Corporation. All rights reserved. (510) 475-0650